JG
HZNP

Joel Greenblatt’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Joel Greenblatt’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-46,602
Closed -$5.39M – 1469
2023
Q3 		$5.39M Buy
46,602
+2,102
+5% +$226K 0.11% 232
2023
Q2 		$4.58M Buy
44,500
+2,841
+7% +$300K 0.1% 267
2023
Q1 		$4.55M Buy
41,659
+2,486
+6% +$275K 0.11% 223
2022
Q4 		$4.46M Buy
39,173
+5,354
+16% +$445K 0.13% 190
2022
Q3 		$2.09M Buy
33,819
+11,454
+51% +$800K 0.06% 380
2022
Q2 		$1.78M Buy
22,365
+575
+3% +$54.5K 0.06% 405
2022
Q1 		$2.29M Buy
21,790
+13,714
+170% +$1.34M 0.07% 324
2021
Q4 		$870K Buy
8,076
+1,221
+18% +$133K 0.03% 586
2021
Q3 		$751K Sell
6,855
-653
-9% -$67.8K 0.03% 547
2021
Q2 		$703K Sell
7,508
-41,325
-85% -$3.8M 0.03% 589
2021
Q1 		$4.5M Buy
48,833
+28,554
+141% +$2.41M 0.2% 146
2020
Q4 		$1.48M Buy
+20,279
New +$1.51M 0.05% 421
2019
Q4 		– Sell
-69,852
Closed -$1.9M – 1281
2019
Q3 		$1.9M Sell
69,852
-137,306
-66% -$3.55M 0.03% 463
2019
Q2 		$4.98M Buy
207,158
+139,840
+208% +$3.55M 0.08% 318
2019
Q1 		$1.78M Buy
+67,318
New +$1.6M 0.03% 517
2017
Q2 		– Sell
-37,797
Closed -$559K – 1150
2017
Q1 		$559K Sell
37,797
-88,669
-70% -$1.44M 0.01% 746
2016
Q4 		$2.05M Buy
+126,466
New +$2.29M 0.03% 507
2016
Q2 		– Sell
-1,053,933
Closed -$17.5M – 1144
2016
Q1 		$17.5M Sell
1,053,933
-1,021,084
-49% -$17.9M 0.2% 172
2015
Q4 		$45M Buy
+2,075,017
New +$40.4M 0.49% 43
2015
Q1 		– Sell
-107,898
Closed -$1.39M – 1069
2014
Q4 		$1.39M Buy
107,898
+27,064
+33% +$339K 0.01% 567
2014
Q3 		$993K Buy
80,834
+23,065
+40% +$268K 0.01% 625
2014
Q2 		$914K Buy
+57,769
New +$825K 0.01% 665

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Joel Greenblatt's HZNP Position: Q4 2023 in Review

Joel Greenblatt sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 46,602 shares — an estimated $5.39M sold.

Joel Greenblatt first reported a position in HZNP in Q2 2014 and held it in 22 quarters. The position peaked at $45M in Q4 2015. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Joel Greenblatt reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Joel Greenblatt sold 46,602 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $5.39M.
  • Joel Greenblatt first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2014 and held it in 22 quarters.
  • Joel Greenblatt's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $45M in Q4 2015.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.